Pyxis Oncology stock forecast
Want to see PYXS full AI Analyst Report?
Pyxis Oncology (PYXS) Stock Forecast & Price Target
PYXS Analyst Ratings
PYXS Stock 12 Month Forecast
Average Price Target
$8.71▲(431.36% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Swayampakula Ramakanth | H.C. Wainwright | $5→$8 | buy | 387.80%Upside | Reiterated | 11/09/26 | ||
| Leonid Timashev | RBC Capital | $6→$7 | buy | 326.83%Upside | Assigned | 11/06/26 | ||
| Stephen Willey | Stifel Nicolaus | $7→$5 | buy | 204.88%Upside | Reiterated | 11/06/26 | ||
| Robert Driscoll | Wedbush | $8→$7 | buy | 326.83%Upside | Reiterated | 11/06/26 | ||
 Unknown AnalystNot Ranked | Guggenheim | $7 | buy | 326.83%Upside | Reiterated | 11/05/26 | ||
| Derek Archila | Wells Fargo | $19 | buy | 1058.54%Upside | Reiterated | 10/16/26 | ||
| Sam Slutsky | LifeSci Capital | $6→$8 | buy | 387.80%Upside | Reiterated | 09/26/26 | ||
| Andy Hsieh | William Blair | ― | hold | ― | Reiterated | 09/09/26 | ||
| Sudan Loganathan | Stephens | $8 | buy | 387.80%Upside | Reiterated | 11/24/25 | ||
| Unknown AnalystNot Ranked | Jefferies | $7.40 | buy | 351.22%Upside | Reiterated | 11/13/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Swayampakula RamakanthH.C. Wainwright | BuyReiterated$5→$8 | 11/09/26 | 387.80%Upside | ||
| Leonid TimashevRBC Capital | BuyAssigned$6→$7 | 11/06/26 | 326.83%Upside | ||
| Stephen WilleyStifel Nicolaus | BuyReiterated$7→$5 | 11/06/26 | 204.88%Upside | ||
| Robert DriscollWedbush | BuyReiterated$8→$7 | 11/06/26 | 326.83%Upside | ||
| Unknown AnalystGuggenheimNot Ranked | BuyReiterated$7 | 11/05/26 | 326.83%Upside | ||
| Derek ArchilaWells Fargo | BuyReiterated$19 | 10/16/26 | 1058.54%Upside | ||
| Sam SlutskyLifeSci Capital | BuyReiterated$6→$8 | 09/26/26 | 387.80%Upside | ||
| Andy HsiehWilliam Blair | HoldReiterated | 09/09/26 | ― | ||
| Sudan LoganathanStephens | BuyReiterated$8 | 11/24/25 | 387.80%Upside | ||
| Unknown AnalystJefferiesNot Ranked | BuyReiterated$7.40 | 11/13/25 | 351.22%Upside |
Best Analysts Covering Pyxis Oncology
Copying Sam Slutsky's trades and holding each position for 3 Months would result in 47.06% of your transactions generating a profit, with an average return of +12.04% per trade.
Copying Sam Slutsky's trades and holding each position for 1 Year would result in 52.94% of your transactions generating a profit, with an average return of +9.69% per trade.
Copying Leonid Timashev's trades and holding each position for 2 Years would result in 30.00% of your transactions generating a profit, with an average return of -8.21% per trade.
PYXS Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 18 | 17 | 15 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 14 | 14 | 20 | 19 | 16 |
In the current month, PYXS has received 15 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. PYXS average Analyst price target in the past 3 months is 8.71.
PYXS Financial Forecast
PYXS Earnings Forecast
Next quarter’s earnings estimate for PYXS is -$0.22 with a range of -$0.31 to -$0.15. The previous quarter’s EPS was -$0.24. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
PYXS Sales Forecast
Next quarter’s sales forecast for PYXS is $25.00K with a range of $0 to $175.00K. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
